LLY vs WST
Lilly (Eli) (LLY) and West Pharmaceutical Services (WST) compared side by side. Lilly (Eli) (LLY) is larger, with a market cap of $1.1T versus $27.6B for West Pharmaceutical Services, about 41.1 times the size. On trailing earnings, LLY is cheaper at 42.7x versus 50.2x for WST.
Head to head
| Metric | LLY | WST |
|---|---|---|
| Market cap | $1.1T | $27.6B |
| P/E (TTM) | 42.7x | 50.2x |
| Forward P/E | 27.0x | 39.3x |
| Revenue (TTM) | $79.7B | $3.3B |
| Revenue growth | 47.7% | 13.8% |
| Gross margin | 83.4% | 36.8% |
| Operating margin | 54.2% | 22.5% |
| Free cash flow | $13.6B | $436.9M |
| Dividend yield | 0.54% | 0.27% |
| 1-year return | +56.1% | +28.0% |
| 5-year return (annual) | +40.5% | -1.2% |
| Max drawdown | -68% | -59% |
| FI Handbook grade | B | C+ |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
LLY vs WST FAQ
Which is bigger, LLY or WST?
Lilly (Eli) (LLY) is larger, with a market cap of $1.1T versus $27.6B for West Pharmaceutical Services, about 41.1 times the size.
Is LLY or WST cheaper?
On trailing earnings, LLY is cheaper at 42.7x versus 50.2x for WST. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, LLY or WST?
LLY returned +56.1% over the past year including dividends, versus +28.0% for WST, through October 23, 2026.
Which pays a higher dividend, LLY or WST?
LLY yields 0.54% versus 0.27% for WST.
Full pages: Lilly (Eli) · West Pharmaceutical Services